IHS Chemical Week

Regions :: North America

Amgen to acquire Onyx Pharmaceuticals for $10.4 billion

1:32 AM MDT | August 26, 2013 | Natasha Alperowicz

Amgen (Thousand Oaks, CA), the world’s largest independent biotechnology company; and Onyx Pharmaceuticals announced on Sunday that their boards of directors have unanimously approved a transaction for Amgen to acquire all of the outstanding shares of Onyx for $125/share in cash. The purchase price is $10.4 billion, or $9.7 billion net of estimated Onyx cash.    Onyx is a global biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer. Onyx has an...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa